SCHEMBL14433979

SCHEMBL14433979

[O-][S+]1c2ccccc2N(CC2CN3CCC2CC3)C2C=CC=CC21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR3A P46098 3/20 0.44
▸ CHRM2 P08172 2/20 0.44
▸ HTR1A P08908 2/20 0.44
▸ ADRA2A P08913 2/20 0.44
▸ CHRM1 P11229 2/20 0.44
▸ DRD1 P21728 2/20 0.44
▸ SLC6A2 P23975 2/20 0.44
▸ SLC6A4 P31645 2/20 0.44
▸ ADRA1A P35348 2/20 0.44
▸ DRD3 P35462 2/20 0.44
▸ SLC6A3 Q01959 2/20 0.44
▸ KCNH2 Q12809 2/20 0.44
▸ EGFR P00533 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ ADORA3 P0DMS8 1/20 0.44
▸ MAPT P10636 1/20 0.44
▸ DRD2 P14416 1/20 0.44
▸ ADRA2B P18089 1/20 0.44
▸ ADRA2C P18825 1/20 0.44
▸ CHRM3 P20309 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14433981 0.73 CHRM2 (0.54) HTR3ACHRM2HTR1AADRA2ACHRM1
SCHEMBL14434182 0.73 CHRM2 (0.54) HTR3ACHRM2HTR1AADRA2ACHRM1
SCHEMBL14434185 0.73 CHRM2 (0.54) HTR3ACHRM2HTR1AADRA2ACHRM1
SCHEMBL14433984 0.63 EGFR (0.40) HTR3ACHRM2HTR1AADRA2ACHRM1
Mequitazine SCHEMBL605366 0.61 CYP2D6 (1.00) HTR3ACHRM2HTR1AADRA2ACHRM1
Mequitazine SCHEMBL29382350 0.61 CYP2D6 (1.00) HTR3ACHRM2HTR1AADRA2ACHRM1
Mequitazine SCHEMBL29376901 0.61 CYP2D6 (1.00) HTR3ACHRM2HTR1AADRA2ACHRM1
Mequitazine SCHEMBL18208 0.61 CYP2D6 (1.00) HTR3ACHRM2HTR1AADRA2ACHRM1
Mequitazine SCHEMBL18207 0.61 CYP2D6 (1.00) HTR3ACHRM2HTR1AADRA2ACHRM1
Mequitazine SCHEMBL604639 0.61 CYP2D6 (1.00) HTR3ACHRM2HTR1AADRA2ACHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007085652-A1 USE OF THE (S) ENANTIOMER OF MEQUITAZINE FOR PREPARING A MEDICAMENT, WHILE AT THE SAME TIME LIMITING GENOMIC TOXICITY PIERRE FABRE MEDICAMENT (FR) 2007-08-02 — — WO disclosed
Send feedback